RESULTS	After 2 months of follow-up in the intention-to-treat analysis , the group treated with irbesartan had fewer patients with recurrent atrial fibrillation ( Kaplan-Meier analysis , 84.79 % versus 63.16 % , P = 0.008 ) .\